Abstract
Background
Although complete tumor resection is accepted as the best means to reduce recurrence, reoperations after lumpectomy are a common problem in breast cancer. The aim of this study was to assess the reoperation rates after primary breast conserving surgery in invasive breast cancer cases diagnosed in Catalonia, Spain, between 2005 and 2011 and to identify variations based on patient and tumour characteristics.
Methods
Women with invasive incident breast cancer identified from the Patient’s Hospital Discharge Database [174.0–174.9 codes of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) as the primary diagnosis] and receiving primary breast conserving surgery were included in the study and were followed up to 3 and 12 months by collecting information about repeat breast cancer surgery.
Results
Reoperation rates after primary breast conserving surgery decreased from 13.0 % in 2005 to 11.7 % in 2011 at 3 months and from 14.2 % in 2005 to 12.9 % in 2011 at 12 months’ follow-up. While breast conservation reoperations saw a slight, non-significant increase in the same period (from 5.7 to 7.3 % at 3 months, and from 6.0 to 7.5 % at 12 months), there was a significant decrease in radical reoperation (from 7.3 to 4.4 % at 3 months and from 8.2 to 5.4 % at 12 months). Overall, additional breast surgeries decreased among younger women.
Conclusions
Despite the rise of breast conserving surgery, reoperation rates following initial lumpectomy in Catalonia decreased by 10 % at 3 and 12 months’ follow-up, remaining low and almost unchanged. Ultimately, there was also a significant decrease in mastectomies.
Similar content being viewed by others
Abbreviations
- BC:
-
Breast cancer
- BCS:
-
Breast conserving surgery
- LR:
-
Local recurrence
- HDD:
-
Hospital discharge database
- PHIN:
-
Personal health identification number
- ICD-9-CM:
-
International Classification of Diseases, 9th revision, Clinical Modification
- ASEDAT:
-
Analysis, selection and extraction of tumor data
- IARC:
-
International Agency for Research on Cancer
- CIS:
-
Carcinoma in situ
- CCI:
-
Charlson comorbidity index
- AJCC:
-
American Joint Committee on Cancer
- AsBrS:
-
American Society of Breast Surgeons
- SSO:
-
Society of Surgical Oncology
- ASTRO:
-
American Society for Radiation Oncology
- ALND:
-
Axillary lymph node dissection
- SLNB:
-
Sentinel lymph node biopsy
- ICD-10-CM/PCS:
-
International Classification of Diseases, 10th revision, Clinical Modification and Procedure Classification System
- OPCS-4:
-
OPCS classification of interventions and procedures version 4
References
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. 2014. http://globocan.iarc.fr. Accessed 15 Jul 2015.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer Incidence and mortality patterns in Europe: estimates for 40 cancers in 2012. Eur J Cancer. 2013;49:1374–403.
Sociedad Española de Oncología Médica (SEOM). Las cifras del cáncer en España. 2014. http://www.seom.org/seomcms/images/stories/recursos/Las_cifras_del_cancer_2014.pdf. Accessed 30 July 2015.
Generalitat de Catalunya: Incidència del Càncer a Catalunya. Càncer. http://cancer.gencat.cat/ca/professionals/estadistiques/incidencia/. Accessed 10 July 2015.
Escribà JM, Pareja L, Esteban L, Gálvez J, Melià A, Roca L, et al. Trends in the surgical procedures of women with incident breast cancer in Catalonia, Spain, over a 7-year period (2005–2011). BMC Res Notes. 2014;. doi:10.1186/1756-0500-7-587.
Rahman GA. Breast conserving therapy: a surgical technique where little can mean more. J Surg Tech Case Rep. 2011;3:1–4.
Jeevan R, Cromwell DA, Trivella M, Kearins O, Pereira J, Sheppard C, et al. Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics. BMJ. 2012;345:e4505.
McCahill LE, Single RM, Aiello Bowles EJ, Feigelson HS, James TA, Barney T, et al. Variability in re-excision following breast conservation surgery. JAMA. 2012;. doi:10.1001/jama.2012.43.
Wilke LG, Czechura T, Wang C, Lapin B, Liederbach E, Winchester DP, et al. Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma. A report from the national cancer data base, 2004–2010. JAMA Surg. 2014;149:1296–305.
Talsma AK, Reedijk AMJ, Damhuis RAM, Westenend PJ, Vles WJ. Re-resection rates after breast conserving surgery as a performance indicator: introduction of a case-mix model to allow comparison between Dutch hospitals. EJSO. 2011;37:357–63.
Ribes J, Gálvez J, Melià A, Clèries R, Messeguer X, Bosch FX. Automatization of a hospital based tumor registry. Gac Sanit. 2005;19:221–8.
Generalitat de Catalunya. Departament de Salut, Servei Català de la Salut. The International Classification of Diseases and Related Health Problems, 9th Revision, Catalan Translation. 8th edition. Barcelona: Pòrtic ed, 2011. http://catsalut.gencat.cat/ca/proveidors-professionals/registres-catalegs/catalegs/diagnostics-procediments/cim-9-mc/. Accessed 1 Aug 2015.
Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–9.
Savu A, Liu Q, Yasui Y. Estimation of relative risk and prevalence ratio. Stat Med. 2010;29:2269–81. doi:10.1002/sim.3989.
Houssami N, Morrow M. Margins in breast conservation: a clinician’s perspective and what the literature tell us. J Surg Oncol. 2014;110:2–7.
Gentilini O, Gahir J. An urgent need to reduce re-operation rates after breast conserving surgery. Gland Surg. 2012;1:159–60.
Harness JK, Giuliano AE, Pockaj BA, Downs-Kelly E. Margins: a status report from the annual meeting of the American society of breast surgeons. Ann Surg Oncol. 2014;. doi:10.1245/s10434-014-3957-2.
Landerscaper J, Attai D, Atisha D, Beitsch P, Bosserman L, Boughey J, et al. Tool-box to reduce lumpectomy reoperations and improve cosmetic outcome in breast cancer patients: the American society of breast surgeons consensus conference. Ann Surg Oncol. 2015;22:3174–83.
Kurniawan ED, Wong MH, Windle I, Rose A, Mou A, Buchanan M, et al. Predictors of surgical margins status in breast conserving surgery within a breast screening program. Ann Surg Oncol. 2008;15:2542–9.
Porter G, Wagar B, Bryant H, Hewitt M, Wai E, Dabbs K, et al. Rates of breast cancer surgery in Canada from 2007/08 to 2009/10. CMJA Open. 2014;. doi:10.9778/cmajo.20130025.
Morrow M, Jagsi R, Alderman K, Griggs JJ, Hawley ST, Hamilton AS, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA. 2009;302:1551–6.
Landercasper J, Whitacre E, Degnim AC, Al-Hamadani M. Reasons for re-excision after lumpectomy for breast cancer: insight from the american society of breast surgeons masterysm database. Ann Surg Oncol. 2014;21:3185–91.
Dabbas N, Cutress RI, Wise M, Yiangou C, Agrawal A. Repeat surgery following breast conservation and intra-operative sentinel lymph node analysis for breast cancer. The Surgeon. 2013;11:235–40.
Bani MR, Lux MP, Heusinger K, Wenkel E, Magener A, Schulz-Wendtland R, et al. Factors correlating with reexcision after breast conserving surgery. EJSO. 2009;35:32–7.
Waljee JF, Hu ES, Newman LA, Alderman AK. Predictors of re-excision among women undergoing breast-conserving surgery for cancer. Ann Surg Oncol. 2008;. doi:10.1245/s10434-007-9777-x.
Ramanah R, Pivot X, Sautiere JL, Maillet R, Riethmuller D. Predictors of re-excision for positive or close margins in breast-conservation therapy for pT1 tumors. Am J Surg. 2008;195:770–4.
Lovrics PJ, Cornacchi SD, Farrokhyar F, Garnett A, Chen V, Franic S, et al. Technical factors, surgeon case volume and positive margin rates after breast conservation surgery for early-stage breast cancer. Can J Surg. 2010;53:305–12.
Coopey S, Smith BL, Hanson S, Buckley J, Hughes KS, Gadd M, et al. The safety of multiple re-excisions after lumpectomy for breast cancer. Ann Surg Oncol. 2011;18:3797–801.
Sabel MS, Rogers K, Griffith K, Jagsi R, Kleer CG, Diehl KA, et al. Residual disease after re-excision lumpectomy for close margins. J Surg Oncol. 2009;99:99–103.
Dieterich M, Dieterich H, Moch H, Rosso C. Re-excision rates and local recurrence in breast cancer patients undergoing breast conserving therapy. Geburtsh Frauenheilk. 2012;. doi:10.1055/s-0032-1327980.
Jung W, Kang E, Kim SM, Kim D, Hwang Y, Sun Y, et al. Factors associated with re-excision after breast-conserving surgery for early-stage breast cancer. J Breast Cancer. 2012;. doi:10.4048/jbc.2012.15.4.412.
Boughey JC, Hieken TJ, Jakub JW, Degnim AC, Grant CS, Farley DR, et al. Impact of analysis of frozen-section margin on reoperation rates in women undergoing lumpectomy for breast cancer: evaluation of the national surgical quality improvement program data. Surgery. 2014;156:190–7.
Yu C, Chiang K, Kuo W, Shen S, Lo Y, Chen S. Low re-excision rate for positive margins in patients treated with ultrasound-guided breast-conserving surgery. The Breast. 2013;22:698–702.
Kryh CG, Pietersen CA, Rahr HB, Christensen RD, Wamberg P, Laudrup MD. Re-resection rates and risk characteristics following breast conserving surgery for breast cancer and carcinoma in situ: a single-centre study of 1575 consecutive cases. The Breast. 2014;23:784–9.
Garvey EM, Senior DA, Pockaj BA, Wasif N, Dueck AC, McCullogh AE, et al. Rates of residual disease with close but negative margins in breast cancer surgery. The Breast. 2015;24:413–7.
Cebollero de Miguel A, Antón A, Hernández A, Hernando J, Torres I, Calera L, et al. C0520 Reexcisión en cirugía oncológica de la mama. Experiencia en nuestro hospital. First Spanish Breast Health Congress, 17–19 Oct 2013, p. 112. http://www.sedim.es/nueva/wp-content/uploads/2014/10/Libro_resumenes_1er-Congreso-Espa%C3%B1ol-de-la-Mama.pdf. Accessed 24 Sep 2015.
Hernández AAT, Benítez VV, Giner MIG, Flores CDT, Correa PP, Hernández JRH. Predictive factors in the development of residual tumor in patients undergoing reoperation after conservative surgery for breast cancer. Rev Senol Patol Mamar. 2015;28:120–6.
Azu M, Abrahamse P, Katz SJ, Jagsi R, Morrow M. What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates. Ann Surg Oncol. 2010;. doi:10.1245/s10434-009-0765-1.
Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, et al. society of surgical oncology-american society for radiation oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol. 2014;. doi:10.1245/S10434-014-3481-4.
Ananthakrishnan P, Balci FL, Crowe JP. Optimizing surgical margins in breast conservation. IJSO. 2012;. doi:10.1155/2012/585670.
Angarita FA, Nadler A, Zerhouni S, Escallon J. Perioperative measures to optimize margin clearance in breast conserving surgery. Surg Oncol. 2014;23:81–91.
Cabioglu N, Hunt KK, Sahin AA, Kuerer HM, Baviera GV, Singletary SE, et al. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol. 2007;14:1458–71.
Rubio IT. Breast conservative surgery in breast cancer: simple can be harder than complex. J Surg Oncol. 2014;110:1.
Acknowledgments
We thank MB and the Catalan Health Department for providing the original data. This study was partially funded by the Institute of Health Carlos III (RTICC: RD12/0036/0053), within the framework of the National Plan of I+D+I 2013-2016 and the European Regional Development Fund (FEDER: a way to build Europe) and the Agència de Gestió d’Ajuts Universitaris I de Recerca–Generalitat de Catalunya (Catalonian Government; Grant Number AGAUR, 2014SGR0635).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare. I wish to confirm that all the authors have carefully read the manuscript and fully approved it. On their behalf, I also state that the manuscript is original and it has not been submitted to other journal. Finally, I wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.
Informed consent
Informed consent was not required because we used administrative databases with anonymized information to the researchers.
Research involving human participants
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Escribà, J.M., Esteban, L., Gálvez, J. et al. Reoperations after primary breast conserving surgery in women with invasive breast cancer in Catalonia, Spain: a retrospective study. Clin Transl Oncol 19, 448–456 (2017). https://doi.org/10.1007/s12094-016-1546-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-016-1546-5